Showing results (921-930 of 2,811) with videos related to

Sort By:
Pageof 282
Expert Opinion on Drug Safety|October 2, 2024
Exploring SGLT-2 inhibitors and sarcopenia in FAERS: a post-marketing surveillance studyZheng Kuai, Yangli Ye, Xiaoyi Zhang, et al.
Expert Opinion on Drug Safety|October 29, 2024
Comprehensive evaluation of leuprorelin-associated adverse events: insights from FDA adverse event reporting systemXiao Tang, Fuchun Zheng, Zifang Ma, et al.
Expert Opinion on Drug Safety|September 12, 2024
The use of denosumab in osteoporosis - an update on efficacy and drug safetyDima L Diab, Nelson B Watts
Expert Opinion on Drug Safety|March 4, 2025
Influence of rapidly increased numbers of reports on adverse events of the COVID-19 vaccine in the Japanese pharmacovigilance database on disproportionality analysis of antineoplastic drug-associated adverse cardiovascular eventsHajime Matsuo, Hiroyuki Tanaka, Kiri Endo, et al.
Expert Opinion on Drug Safety|March 4, 2025
Post-marketing safety monitoring of tirzepatide: a pharmacovigilance study based on the FAERS databaseHan Chen, Yuhang Ding, Yongqi Shan
Expert Opinion on Drug Safety|February 28, 2025
Safety assessment of esomeprazole: real-world adverse event signal mining and analysis based on FAERS databaseBojing Wang, Shu Huang, Shiqi Li, et al.
Expert Opinion on Drug Safety|February 26, 2025
Effects of nirmatrelvir/ritonavir (Paxlovid) on the nervous system: analysis on adverse events released by FDACaixia Gao, Zhihui Liu, Zhen Zou, et al.
Expert Opinion on Drug Safety|February 18, 2025
Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysisLama Alfehaid, Majed Alyami, Sumaya Almohareb, et al.
Expert Opinion on Drug Safety|February 18, 2025
Drug-induced skin ulcer: real-world pharmacovigilance analysis based on the FDA adverse event reporting systemQiubai Jin, Jiufei Fang, Feihong Ren, et al.
Expert Opinion on Drug Safety|February 15, 2025
Impact of baseline glucocorticoids (GCs) on cardiotoxic events and myocardial damage related to immune checkpoint inhibitors: a retrospective clinical researchQiaoyun Wang, Haixia Zhang, Yawen Chen, et al.
Pageof 282